Gain Therapeutics, Inc.

GANX

—

Advanced chart & tools →

Gain Therapeutics, Inc.GANX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.61

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$55,180

Net income

$-20.16M

Net margin

-36537.0%

Gross margin

—

Dividends & financials

Gain Therapeutics, Inc. (GANX) reported revenue of $55,180 and net income of $-20.16M, or $-0.61 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.